Boehringer Ingelheim Revenue and Competitors

Ridgefield, CT USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Boehringer Ingelheim's estimated annual revenue is currently $10.2B per year.(i)
  • Boehringer Ingelheim's estimated revenue per employee is $201,000

Employee Data

  • Boehringer Ingelheim has 50709 Employees.(i)
  • Boehringer Ingelheim grew their employee count by 3% last year.

Boehringer Ingelheim's People

NameTitleEmail/Phone
1
Corporate VP Analytics, Insights and ExcellenceReveal Email/Phone
2
Chief Staff to CEO at Boehringer Ingelheim Animal HealthReveal Email/Phone
3
Head Nonclinical Drug Safety Germany, VPReveal Email/Phone
4
Corporate VP Global Supply Chain Management & StrategyReveal Email/Phone
5
Corporate VP Human ResourcesReveal Email/Phone
6
Corporate VP, Global Head Marketing and Sales ExcellenceReveal Email/Phone
7
CFO / Head Finance and Administration FranceReveal Email/Phone
8
Corporate VP, Head Global Marketing, OncologyReveal Email/Phone
9
CFOReveal Email/Phone
10
Chief AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69340M1073104%N/A$308.4B
#2
N/A108295-1%N/AN/A
Add Company

What Is Boehringer Ingelheim?

For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees

keywords:N/A

N/A

Total Funding

50709

Number of Employees

$10.2B

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Boehringer Ingelheim News

2022-04-20 - Boehringer Ingelheim Animal Health Plans $57M Expansion In Georgia

When complete, the expansion will bring Boehringer Ingelheim's Global Innovation footprint in Athens to nearly 115,000 square feet and...

2022-04-20 - José Manautou appointed Boehringer-Ingelheim ...

Chair in Mechanistic Toxicology. The endowed chair was established in 2006 with a gift of $1.2 million from Boehringer-Ingelheim Pharmaceuticals...

2022-04-20 - Boehringer Ingelheim launches initiative to promote heart ...

Boehringer Ingelheim is teaming with Eli Lilly and Co. on the new initiative Hear Your Heart, which is designed to empower Black and Latina...

2021-10-21 - Ex­clu­sive: Athi­ra CEO Leen Kawas re­signs af­ter in­ves­ti­ga­tion finds she ma­nip­u­lat­ed da­ta

Six years ago, Boehringer Ingelheim announced that a new manufacturing plant focused on large-scale cell culture technology would be erected in Vienna, marking the largest investment in the company’s history. Last week, the site became operational. The site will add another 185,000 liters of pr ...